REFLEX Study Results Show Treatment with Rebif Delays Conversion to MS in Patients with First Clinical Signs of the Disease - Drugs.com MedNews
Links shared publicly online about this topic.
- 776total visits
REFLEX Study Results Show Treatment with Rebif Delays Conversion to MS in Patients with First Clinical Signs of the Disease - Drugs.com MedNews
Study met its primary endpoint Risk of converting to multiple sclerosis (McDonald criteria) was reduced by half in patients treated with Rebif 44 mcg three time
View full resource at drugs.com
Tags: Multiple Sclerosis, Multiple Sclerosis Medication, Disease and Condition, Drug, Rebif, disease
Most Recently Shared on October 25, 2010 at 2:12 pm By:
REFLEX Study Results Show Treatment with Rebif Delays Conversion to MS in Patients with First Clinical Signs ... http://bit.ly/bzTgZJ #drug
Advertisement
